European Union · Question · QUESTION_WRITTEN
E-9-2021-001134
Sale of Covid-19 vaccines on parallel or secondary markets in the EU
Introduced
25 February 2021
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 June 2021
Records
Official question E-9-2021-001134 from European Union at European Parliament. Dated 25 February 2021. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Sale of COVID-19 vaccines on parallel and secondary markets in the EU
Sale of COVID-19 vaccines on parallel and secondary markets in the EU
QUESTION_WRITTEN · EN · 11 March 2021
Sale of COVID-19 vaccines on parallel and secondary markets in the EU
QUESTION_WRITTEN · EN · 11 March 2021
Sale of COVID-19 vaccines on parallel and secondary markets in the EU
QUESTION_WRITTEN · EN · 11 March 2021
Answer
QUESTION_WRITTEN_ANSWER · 28 June 2021
Vendita di vaccini anti Covid-19 su mercati paralleli o secondari nell'UE
QUESTION_WRITTEN · IT · 11 March 2021
Vendita di vaccini anti Covid-19 su mercati paralleli o secondari nell'UE
QUESTION_WRITTEN · IT · 11 March 2021
Vendita di vaccini anti Covid-19 su mercati paralleli o secondari nell'UE
QUESTION_WRITTEN · IT · 11 March 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.